Tenecteplase (TNK), a genetically modified fibrinolytic agent, is increasingly used for acute ischaemic stroke because of its single-bolus administration and fibrin specificity. Haemarthrosis is an uncommon manifestation of bleeding that may occur in the setti... ...

请注册登录后继续浏览